Srinivasan Venkatesh 4
4 · SUTRO BIOPHARMA, INC. · Filed Apr 15, 2025
Insider Transaction Report
Form 4
Srinivasan Venkatesh
CHIEF TECH OP OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-04-11+21,250→ 59,683 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-04-11−21,250→ 21,250 totalExp: 2026-04-11→ Common Stock (21,250 underlying) - Tax Payment
Common Stock
2025-04-11$0.60/sh−7,603$4,562→ 52,080 total
Footnotes (3)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total award annually beginning on April 11, 2023, subject to continued service through each vesting date.